The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19

To effectively respond to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an increasing number of researchers are focusing on the antiviral activity of cepharanthine (CEP), which is a clinically approved drug being used for over 70 years. This review aims to provide a brief overview of...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Binbin, Zheng, Li, Li, Yali, Sun, Wenfang, Liu, Yang, Li, Liushui, Pang, Jingyao, Chen, Jing, Li, Jiaxin, Cheng, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423819/
https://www.ncbi.nlm.nih.gov/pubmed/37583901
http://dx.doi.org/10.3389/fphar.2023.1098972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423819/
https://www.ncbi.nlm.nih.gov/pubmed/37583901
http://dx.doi.org/10.3389/fphar.2023.1098972

Ejemplares similares